IRONWOOD PHARMACEUTICALS, INC. (IRWD) Operating cash flow 2016–2025
IRONWOOD PHARMACEUTICALS, INC. (IRWD) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
$127.0MFY2025 · since FY2016: -$25.9M → $127.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $127.0M | +22.7% |
| FY2024 | $103.5M | -43.5% |
| FY2023 | $183.4M | -33.0% |
| FY2022 | $273.8M | +4.5% |
| FY2021 | $261.9M | +55.1% |
| FY2020 | $168.8M | +1474.2% |
| FY2019 | $10.7M | +115.1% |
| FY2018 | -$70.9M | +29.6% |
| FY2017 | -$100.8M | -288.5% |
| FY2016 | -$25.9M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More IRWD financial trends
IRWD RevenueIRWD Net incomeIRWD Net marginIRWD Gross profitIRWD Gross marginIRWD Operating incomeIRWD Operating marginIRWD Free cash flowIRWD Capital expendituresIRWD Return on equityIRWD Stock buybacksIRWD Dividends paidIRWD Total assetsIRWD Total liabilitiesIRWD Shareholders’ equityIRWD overview →